Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient

被引:38
作者
Vanacker, A. [1 ]
Fabre, G. [2 ]
Van Dorpe, J. [3 ]
Peetermans, W. E. [4 ]
Maes, B. [1 ]
机构
[1] Heilig Hartziekenhuis Roeselare Menen, Dept Nephrol, B-8800 Roeselare, Belgium
[2] Heilig Hartziekenhuis Roeselare Menen, Dept Plast & Reconstruct Surg, B-8800 Roeselare, Belgium
[3] Heilig Hartziekenhuis Roeselare Menen, Dept Pathol, B-8800 Roeselare, Belgium
[4] Univ Hosp, Dept Gen Internal Med, B-3000 Louvain, Belgium
关键词
squamous cell carcinoma; voriconazole;
D O I
10.1111/j.1600-6143.2007.02140.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
A 69-year-old man, with a history of end-stage renal disease due to polyarteritis nodosa, followed by invasive pulmonary aspergillosis secondary to cyclophosphamide and corticosteroids, received a renal transplant 2 years ago under prophylactic treatment with voriconazole. Because of the severity of the aspergillosis, it was decided to continue voriconazole for a prolonged period. Eighteen months after transplantation, the patient developed a severe facial phototoxic reaction. A few months later, he developed multiple actinic keratoses and a large, rapidly expanding, poorly differentiated squamous cell carcinoma (SCC) with perineural invasion and metastatic lymph nodes, necessitating radical surgery and radiotherapy. Voriconazole therapy has been suggested to be involved in the development of multi-focal invasive SCC when complicated by a phototoxic reaction. Therefore, an alternative antifungal prophylaxis regimen (for instance with posaconazole) should be considered when evaluating patients for solid organ transplantation who are at high risk for the development of cutaneous malignancies.
引用
收藏
页码:877 / 880
页数:4
相关论文
共 23 条
  • [1] [Anonymous], 2002, NEPHROL DIAL TRAN S4
  • [2] CARLINI A, 1998, NEPHROL DIAL TRANSPL, V1659, P2661
  • [3] Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans' cells in sun exposed and sun protected skin
    Carneiro, RV
    Sotto, MN
    Azevedo, LS
    Ianhez, LE
    Rivitti, EA
    [J]. CLINICAL TRANSPLANTATION, 2005, 19 (01) : 115 - 121
  • [4] Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: A prospective study in Queensland, Australia
    Carroll, RP
    Ramsay, HM
    Fryer, AA
    Hawley, CM
    Nicol, DL
    Harden, PN
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (03) : 676 - 683
  • [5] Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials
    Chen, K
    Craig, JC
    Shumack, S
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (03) : 518 - 523
  • [6] Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
    Cornely, Oliver A.
    Maertens, Johan
    Winston, Drew J.
    Perfect, John
    Ullmann, Andrew J.
    Walsh, Thomas J.
    Helfgott, David
    Holowiecki, Jerzy
    Stockelberg, Dick
    Goh, Yeow-Tee
    Petrini, Mario
    Hardalo, Cathy
    Suresh, Ramachandran
    Angulo-Gonzalez, David
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04) : 348 - 359
  • [7] Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
    Denning, DW
    Ribaud, P
    Milpied, N
    Caillot, D
    Herbrecht, R
    Thiel, E
    Haas, A
    Ruhnke, M
    Lode, H
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) : 563 - 571
  • [8] Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole
    Denning, DW
    Griffiths, CEM
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2001, 26 (08) : 648 - 653
  • [9] The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy
    Harbarth, S
    Pestotnik, SL
    Lloyd, JF
    Burke, JP
    Samore, MH
    [J]. AMERICAN JOURNAL OF MEDICINE, 2001, 111 (07) : 528 - 534
  • [10] Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
    Herbrecht, R
    Denning, DW
    Patterson, TF
    Bennett, JE
    Greene, RE
    Oestmann, JW
    Kern, WV
    Marr, KA
    Ribaud, P
    Lortholary, O
    Sylvester, R
    Rubin, RH
    Wingard, JR
    Stark, P
    Durand, C
    Caillot, D
    Thiel, E
    Chandrasekar, PH
    Hodges, MR
    Schlamm, HT
    Troke, PF
    de Pauw, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) : 408 - 415